Characteristics | Training set | Validation set | p value |
---|---|---|---|
Age | 67.89 ± 6.35 | 68.50 ± 6.32 | 0.292 |
BMI | 26.16 ± 3.55 | 25.68 ± 3.10 | 0.369 |
Gender | Â | Â | 0.368 |
 Male | 122 (35.1%) | 45 (30.4%) |  |
 Female | 226 (64.9%) | 103 (69.6%) |  |
High blood pressure | Â | Â | 0.503 |
 Yes | 175 (50.3%) | 80 (54.1%) |  |
 No | 173 (49.7%) | 68 (45.9%) |  |
Diabetes mellitus | Â | Â | 0.702 |
 Yes | 46 (13.2%) | 17 (11.5%) |  |
 No | 302 (86.8%) | 131 (88.5%) |  |
Coronary heart disease | Â | Â | 0.797 |
 Yes | 22 (6.3%) | 11 (7.4%) |  |
Characteristics | Training set | Validation set | p value |
 No | 326 (93.7%) | 137 (92.6%) |  |
White blood cell | Â | Â | 1 |
 Abnormal | 15 (4.3%) | 6 (4.1%) |  |
 Normal | 333 (95.7%) | 142 (95.9%) |  |
Red blood cell | Â | Â | 0.653 |
 Abnormal | 118 (33.9%) | 54 (36.5%) |  |
 Normal | 230 (66.1%) | 94 (63.5%) |  |
Hemoglobin | Â | Â | 1 |
 Abnormal | 0 (0%) | 0 (0%) |  |
 Normal | 348 (100%) | 148 (100%) |  |
Hematocrit | Â | Â | 0.671 |
 Abnormal | 130 (37.4%) | 59 (39.9%) |  |
 Normal | 218 (62.6%) | 89 (60.1%) |  |
Mean Corpuscular Volume | Â | Â | 0.115 |
 Abnormal | 11 (3.2%) | 10 (6.8%) |  |
 Normal | 337 (96.8%) | 138 (93.2%) |  |
Mean corpuscular hemoglobin | Â | Â | 0.548 |
 Abnormal | 13 (3.7%) | 8 (5.4%) |  |
 Normal | 335 (96.3%) | 140 (94.6%) |  |
Mean corpuscular hemoglobin concentration | Â | Â | 0.451 |
 Abnormal | 35 (10.1%) | 11 (7.4%) |  |
 Normal | 313 (89.9%) | 137 (92.6%) |  |
Red blood cell volume distribution width SD | Â | Â | 0.303 |
 Abnormal | 72 (20.7%) | 24 (16.2%) |  |
 Normal | 276 (79.3%) | 124 (83.8%) |  |
Red blood cell volume distribution width CV | Â | Â | 0.828 |
 Abnormal | 59 (17%) | 27 (18.2%) |  |
 Normal | 289 (83%) | 121(81.8%) |  |
Platelet | Â | Â | 0.723 |
 Abnormal | 19 (5.5%) | 10 (6.8%) |  |
 Normal | 329 (94.5%) | 138 (93.2%) |  |
Platelet crit | Â | Â | 0.552 |
 Abnormal | 61 (17.5%) | 30 (20.3%) |  |
 Normal | 287 (82.5%) | 118 (79.7%) |  |
Mean Platelet Volume | Â | Â | 0.963 |
 Abnormal | 87 (25%) | 36 (24.3%) |  |
 Normal | 261 (75%) | 112 (75.7%) |  |
Platelet-larger cell ratio | Â | Â | 0.963 |
 Abnormal | 87 (25%) | 36 (24.3%) |  |
 Normal | 261 (75%) | 112 (75.7%) |  |
Platelet distribution width | Â | Â | 0.262 |
 Abnormal | 172 (49.4%) | 82 (55.4%) |  |
 Normal | 176 (50.6%) | 66 (44.6%) |  |
Characteristics | Training set | Validation set | p value |
Neutrophil | Â | Â | 0.325 |
 Abnormal | 18 (5.2%) | 4 (2.7%) |  |
 Normal | 330 (94.8%) | 144 (97.3%) |  |
Lymphocyte | Â | Â | 0.394 |
 Abnormal | 34 (9.8%) | 19 (12.8%) |  |
 Normal | 314 (90.2%) | 129 (87.2%) |  |
Monocyte | Â | Â | 0.074 |
 Abnormal | 35 (10.1%) | 24 (16.2%) |  |
 Normal | 313 (89.9%) | 124 (83.8%) |  |
Eosinophils | Â | Â | 1 |
 Abnormal | 329 (94.5%) | 140 (94.6%) |  |
 Normal | 19 (5.5%) | 8 (5.4%) |  |
Basophil | Â | Â | 0.410 |
 ≥ 0.06 | 41 (11.8%) | 13 (8.8%) |  |
 <0.06 | 307 (88.2%) | 135 (91.2%) |  |
Neutrophil% | Â | Â | 0.641 |
 Abnormal | 16 (4.6%) | 9 (6.1%) |  |
 Normal | 332 (95.4%) | 139 (93.9%) |  |
Lymphocyte% | Â | Â | 0.202 |
 Abnormal | 32 (9.2%) | 20 (13.5%) |  |
 Normal | 316 (90.8%) | 128 (86.5%) |  |
Monocyte% | Â | Â | 0.330 |
 Abnormal | 316 (90.8%) | 139 (93.9%) |  |
 Normal | 32 (9.2%) | 9 (6.1%) |  |
Eosinophils% | Â | Â | 1 |
 Abnormal | 23 (6.6%) | 10 (6.8%) |  |
 Normal | 325 (93.4%) | 138 (93.2%) |  |
Basophil% | Â | Â | 0.285 |
 ≥ 1 | 33 (9.5%) | 9 (6.1%) |  |
 <1 | 315 (90.5%) | 139 (93.9%) |  |
Alanine amino transferase | Â | Â | 0.953 |
 Abnormal | 26 (7.5%) | 12 (8.1%) |  |
 Normal | 322 (92.5%) | 136 (91.9%) |  |
Aspartate amino transferase | Â | Â | 0.828 |
 Abnormal | 32 (9.2%) | 12 (8.1%) |  |
 Normal | 316 (90.8%) | 136 (91.9%) |  |
AST/ALT | Â | Â | 0.247 |
 Abnormal | 4 (1.1%) | 4 (2.7%) |  |
 Normal | 344 (98.9%) | 144 (97.3%) |  |
Total bilirubin | Â | Â | 1 |
 >21 | 14 (4%) | 6 (4.1%) |  |
 ≤ 21 | 334 (96%) | 142 (95.9%) |  |
Direct bilirubin | Â | Â | 1 |
Characteristics | Training set | Validation set | p value |
 >4 | 13 (3.7%) | 6 (4.1%) |  |
 ≤ 4 | 335 (96.3%) | 142 (95.9%) |  |
Indirect bilirubin | Â | Â | 1 |
 Abnormal | 330 (94.8%) | 140 (94.6%) |  |
 Normal | 18 (5.2%) | 8 (5.4%) |  |
Total protein | Â | Â | 0.368 |
 Abnormal | 288 (82.8%) | 128 (86.5%) |  |
 Normal | 60 (17.2%) | 20 (13.5%) |  |
Serum albumin | Â | Â | 0.409 |
 Abnormal | 152 (43.7%) | 58 (39.2%) |  |
 Normal | 196 (56.3%) | 90 (60.8%) |  |
Globulin | Â | Â | 1 |
 Abnormal | 0 (0%) | 0 (0%) |  |
 Normal | 348 (100%) | 148 (100%) |  |
A/G | Â | Â | 0.517 |
 Abnormal | 79 (22.7%) | 29 (19.6%) |  |
 Normal | 269 (77.3%) | 119 (80.4%) |  |
Blood Urea Nitrogen | Â | Â | 0.502 |
 Abnormal | 62 (17.8%) | 22 (14.9%) |  |
 Normal | 286 (82.2%) | 126 (85.1%) |  |
Creatinine | Â | Â | 0.955 |
 Abnormal | 73 (21%) | 30 (20.3%) |  |
 Normal | 275 (79%) | 118 (79.7%) |  |
K | Â | Â | 0.201 |
 Abnormal | 34 (9.8%) | 21 (14.2%) |  |
 Normal | 314 (90.2%) | 127 (85.8%) |  |
Na | Â | Â | 0.193 |
 Abnormal | 20 (5.7%) | 14 (9.5%) |  |
 Normal | 328 (94.3%) | 134 (90.5%) |  |
CL | Â | Â | 1 |
 Abnormal | 29 (8.3%) | 13 (8.8%) |  |
 Normal | 319 (91.7%) | 135 (91.2%) |  |
Ca | Â | Â | 1 |
 Abnormal | 27 (7.8%) | 12 (8.1%) |  |
 Normal | 321 (92.2%) | 136 (91.9%) |  |
Procalcitonin | Â | Â | 0.639 |
 ≥ 0.51 | 27 (7.8%) | 9 (6.1%) |  |
 <0.51 | 321 (92.2%) | 139 (93.9%) |  |
Glucose | Â | Â | Â |
 Abnormal | 0 (0%) | 0 (0%) |  |
 Normal | 348 (100%) | 148 (100%) |  |
PT | Â | Â | 0.194 |
 Abnormal | 44 (12.6%) | 26 (17.6%) |  |
Characteristics | Training set | Validation set | p value |
 Normal | 304 (87.4%) | 122 (82.4%) |  |
INR | Â | Â | 0.323 |
 Abnormal | 4 (1.1%) | 0 (0%) |  |
 Normal | 344 (98.9%) | 148 (100%) |  |
PT% | Â | Â | 0.267 |
 Abnormal | 16 (4.6%) | 3 (2%) |  |
 Normal | 332 (95.4%) | 145 (98%) |  |
FIB | Â | Â | 0.714 |
 Abnormal | 30 (8.6%) | 15 (10.1%) |  |
 Normal | 318 (91.4%) | 133 (89.9%) |  |
APTT | Â | Â | 0.250 |
 Abnormal | 13 (3.7%) | 2 (1.4%) |  |
 Normal | 335 (96.3%) | 146 (98.6%) |  |
TT | Â | Â | 0.740 |
 Abnormal | 7 (2%) | 4 (2.7%) |  |
 Normal | 341 (98%) | 144 (97.3%) |  |
D-Dimer | Â | Â | 0.658 |
 ≥ 0.55 | 95 (27.3%) | 44 (29.7%) |  |
 <0.55 | 253 (72.7%) | 104 (70.3%) |  |
C reactive protein | Â | Â | 0.863 |
 <5 | 48 (13.8%) | 22 (14.9%) |  |
 ≥ 5 | 300 (86.2%) | 126 (85.1%) |  |